Early abciximab administration in acute myocardial infarction treated with primary coronary intervention.

被引：0
|
作者：
Bellandi, F [1 ]
Leoncini, M [1 ]
Maioli, M [1 ]
Toso, A [1 ]
Gallopin, M [1 ]
Dabizzi, RP [1 ]
机构：
[1] Div Cardiol, Prato, Italy
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：236E / 236E
页数：1
相关论文
共 50 条
  • [1] Early abciximab administration in acute myocardial infarction treated with primary coronary intervention
    Bellandi, F
    Maioli, M
    Leoncini, M
    Toso, A
    Dabizzi, RP
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 108 (01) : 36 - 42
  • [2] Intracoronary abciximab downstream of the coronary occlusion may increase myocardial salvage in acute myocardial infarction treated with primary coronary intervention.
    Bellandi, F
    Leoncini, M
    Maioli, M
    Gallopin, M
    Dabizzi, RP
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (6A): : 156H - 157H
  • [3] Primary percutaneous coronary intervention in acute myocardial infarction: Abciximab and early intervention as determinants of favorable results
    Navarro, E
    Cantarelli, M
    Goncalves, R
    Castello, H
    Giopatto, S
    Salome, L
    Friolani, S
    Lara, G
    Tosi, M
    Soubhia, R
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 114L - 114L
  • [4] Intracoronary abciximab downstream of coronary occlusion may increase myocardial salvage in acute myocardial infarction treated with primary coronary intervention
    Bellandi, F
    Leoncini, M
    Maioli, M
    Gallopin, M
    Sestini, S
    Coppola, A
    Dabizzi, RP
    CIRCULATION, 2002, 106 (19) : 535 - 535
  • [5] Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI trial)
    Maioli, Mauro
    Bellandi, Francesco
    Leoncini, Mario
    Toso, Anna
    Dabizzi, Roberto Piero
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (14) : 1517 - 1524
  • [6] Management of Nonculprit Vessel in Acute Myocardial Infarction with Multivessel Disease Treated by Primary Percutaneous Coronary Intervention.
    Jeong, Hae Chang
    Sim, Doo Sun
    Yoon, Nam Sik
    Yoon, Hyun Ju
    Kim, Kye Hun
    Park, Hyung Wook
    Kim, Ju Han
    Jeong, Myung Ho
    Cho, Jeong Gwan
    Park, Jong Chun
    Kang, Jung Chaee
    Ahn, Youngkeun
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (9A): : 40B - 40B
  • [7] A randomized evaluation of early administration of reteplase plus abciximab or abciximab alone prior to percutaneous coronary intervention in patients with acute myocardial infarction
    Kastrati, A
    Mehilli, J
    Schlotterbeck, K
    Dotzer, F
    Dirschinger, J
    Nekolla, S
    Seyfarth, M
    Martinof, S
    Clermont, G
    Markwardt, C
    Kalina, C
    Schmitt, C
    Schwaiger, M
    Schömig, A
    CIRCULATION, 2003, 108 (21)
  • [8] Early abciximab administration during transfer for primary percutaneous coronary intervention. Is there a time benefit therapeutic window?
    Bastos Fernandez, G.
    Carrillo Guevara, J. E.
    Paredes Galan, E.
    Baz Alonso, J. A.
    Ocaranza Sanchez, R.
    Ortiz Saez, A.
    Gomez Blazquez, I.
    Sterling Duarte, J.
    Iniguez Romo, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 207 - 208
  • [9] Therapeutic window in early abciximab administration in ST-elevation myocardial infarction during transfer for primary percutaneous coronary intervention
    Bastos Fernandez, G.
    Jimenez Diaz, V. A.
    De Miguel Castro, A. A.
    Paredes Galan, E.
    Ortiz Saez, A.
    Gomez Blazquez, I.
    Villanueva Benito, I.
    Baz Alonso, J. A.
    Iniguez Romo, A.
    EUROPEAN HEART JOURNAL, 2011, 32 : 419 - 419
  • [10] Predictors of cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with primary percutaneous coronary intervention.
    Conde-Vela, C
    Moreno, R
    Hernandez, R
    Perez-Vizcayno, JM
    Alfonso, F
    Escaned, J
    Banuelos, C
    Macaya, C
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 238E - 238E
12345